Table 2. Number, SMR and 95%CI around the median time to suicide in lung cancer of 7 months (n = 739).
| Suicides in ≤7 Months (n = 296) | Suicides in >7 Months (n = 443) | ||||||
|---|---|---|---|---|---|---|---|
| No. | % | SMR (95%CI) | No. | % | SMR (95%CI) | ||
| Sex (n = 739) | Female | 30 | 10.14 | 6.92 (4.67–9.89) | 53 | 11.96 | 2.55 (1.91–3.34) |
| Male | 266 | 89.86 | 8.84 (7.8-9.96) | 390 | 88.04 | 3.20 (2.89–3.53) | |
| Race (n = 739) | White | 273 | 92.23 | 8.59 (7.6–9.67) | 413 | 93.23 | 3.11 (2.82–3.43) |
| Black | 6 | 2.03 | 4.02 (1.48–8.76) | 16 | 3.61 | 3.07 (1.75–4.98) | |
| Asian | 17 | 5.74 | 13.72 (7.68–22.62) | 14 | 3.16 | 3 (1.64–5.04) | |
| Marital Status (n = 699) | Single | 31 | 11.36 | 10.90 (7.40–15.47) | 43 | 10.09 | 3.95 (2.86–5.32) |
| Married | 167 | 61.17 | 7.29 (6.23–8.49) | 279 | 65.49 | 2.70 (2.39–3.04) | |
| Divorced | 24 | 8.79 | 8.31 (5.33–12.37) | 53 | 12.44 | 5.16 (3.87–6.75) | |
| Widowed | 51 | 18.68 | 11.63 (8.66–15.30) | 51 | 11.97 | 3.99 (2.97–5.25) | |
| Age (n = 739) | <45 | 3 | 1.01 | 1.88 (0.05–10.45) | 18 | 4.06 | 3.05 (1.58–5.33) |
| 45–49 | 8 | 2.70 | 6.38 (2.76–12.57) | 17 | 3.84 | 2.20 (1.28–3.53) | |
| 50–54 | 13 | 4.39 | 5.43 (2.89–9.28) | 33 | 7.45 | 2.47 (1.70–3.47) | |
| 55–59 | 31 | 10.47 | 8.39 (5.70–11.91) | 58 | 13.09 | 3.15 (2.39–4.08) | |
| 60–64 | 37 | 12.50 | 8.01 (5.64–11.04) | 74 | 16.70 | 3.24 (2.55–4.07) | |
| 65–69 | 48 | 16.22 | 8.82 (6.50–11.70) | 91 | 20.54 | 3.68 (2.97–4.52) | |
| 70–74 | 69 | 23.31 | 12.02 (9.35–15.21) | 77 | 17.38 | 3.48 (2.75–4.35) | |
| 75–79 | 43 | 14.53 | 8.29 (6–11.17) | 47 | 10.61 | 2.93 (2.16–3.90) | |
| 80–84 | 37 | 12.50 | 11.08 (7.80–15.27) | 23 | 5.19 | 3.20 (2.03–4.80) | |
| 85+ | 7 | 2.36 | 3.65 (1.47–7.52) | 5 | 1.13 | 1.76 (0.57–4.12) | |
| Grade (n = 739) | Grade I | 4 | 1.35 | 3.10 (0.84–7.93) | 20 | 4.51 | 1.92 (1.17–2.97) |
| Grade II | 25 | 8.45 | 5.67 (3.67–8.38) | 69 | 15.58 | 2.39 (1.86–3.02) | |
| Grade III | 69 | 23.31 | 7.83 (6.09–9.90) | 119 | 26.86 | 2.97 (2.46–3.55) | |
| Grade IV | 37 | 12.50 | 8.57 (6.03–11.81) | 65 | 14.67 | 4.81 (3.72–6.14) | |
| Unknown | 161 | 54.39 | 10.32 (8.78–12.04) | 170 | 38.37 | 3.41 (2.91–3.96) | |
| Histology (n = 525) | Adenocarcinoma | 73 | 37.24 | 8.68 (6.81–10.92) | 116 | 35.26 | 3 (2.48–3.60) |
| Squamous | 60 | 30.61 | 6.73 (5.14–8.66) | 132 | 40.12 | 3.18 (2.66–3.77) | |
| Small-cell carcinoma | 39 | 19.90 | 11.16 (7.94–15.26) | 40 | 12.16 | 5.84 (4.17–7.95) | |
| Large cell carcinoma | 13 | 6.63 | 6.87 (3.66–11.75) | 25 | 7.60 | 3.26 (2.11–4.81) | |
| Carcinoid tumour | 0 | 0.00 | 0 (0–12.26) | 9 | 2.74 | 1.35 (0.62–2.57) | |
| NSCLC | 11 | 5.61 | 7.93 (3.96–14.18) | 7 | 2.13 | 2.05 (0.82–4.22) | |
| Stage (n = 398) | Localised | 12 | 6.45 | 2.82 (1.46–4.93) | 72 | 33.96 | 1.94 (1.52–2.45) |
| Regional | 44 | 23.66 | 7.04 (5.11–9.45) | 79 | 37.26 | 2.75 (2.18–3.43) | |
| Distant | 130 | 69.89 | 13.87 (11.59–16.47) | 61 | 28.77 | 5.01 (3.83–6.44) | |
| Surgical treatment (n = 458) | Not recommended | 117 | 47.95 | 10.47 (8.66–12.55) | 76 | 35.51 | 4.02 (3.17–5.03) |
| Recommended but not performed | 116 | 47.54 | 11.24 (9.29–13.48) | 116 | 54.21 | 6.23 (5.15–7.47) | |
| Recommended but refused | 6 | 2.46 | 12.88 (4.73–28.04) | 10 | 4.67 | 9.10 (4.36–16.74) | |
NSCLC non-small cell lung cancer